Share this event on:

  • LinkedIn

Recomend this page

Thank you, we sent your recommendation to the desired recipient.

Sorry, this functionality is not available right now.
Please try with this link. Thank you.

"CORONA" - Penta Foundation - € 50,000

'CORONA' - Penta Foundation - € 50,000

The UniCredit Foundation confirms its commitment to support pediatric scientific research and its role as a partner in extremely topical international research to understand the effects of the pandemic on children

Fondazione-Penta-hugues-de-buyer

 

 

In 2020, the UniCredit Foundation wished to stand by the Penta Foundation as they launched the CORONA (COhort platfoRm for Optimal data driven maNagement of pAndemics) project, a study aimed at understanding the effects of the Covid 19 pandemic on children. The UniCredit  Foundation's contribution will aid the study of the epidemiological characteristics and clinical outcomes of pediatric patients with confirmed SARS-COV-2 infection and correlated risk factors, as well as the relative effects on the resiliency of young people in managing the impact of pandemics on their lives. By collecting data exclusively on the pediatric population, the study aims to identify which factors influence the development of the disease, its severity, its long-term impact, and how it interacts with past illnesses in order to support vaccine campaigns and treatments that are more targeted and efficient.


The study is supported by the Penta Foundation, which is an organization of the highest international renown with a wide geographical network of 130 centers in 42 countries. Penta's research partners include University College London, the Research Institute Hospital of Madrid, and the Department of Women's and Children's Health at the University of Padua.

The Partner - Penta Foundation NGO


The Foundation was formed in 2004 to treat HIV and related diseases as a legal body that coordinates the Penta network, which was founded in 1991 and seeks to discover and implement the best ways to prevent, diagnose and cure diseases in children.
In 2011, Penta officially became PENTA ID (Infectious Diseases), a change that became necessary in order to incorporate the skills that Penta had gained in more than 20 years of successful operations in the HIV sector and the need for research on other infectious pediatric diseases. Today, the Penta network enjoys international recognition, with a wide geographical network of over 130 centers in 42 countries. It is a leading organization in the field of children's health, with the aim of reducing the frequency and
consequences of infectious pediatric diseases.